4//SEC Filing
Rosol Michael Stanley 4
Accession 0001437749-20-002042
CIK 0000810509other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:17 PM ET
Size
5.0 KB
Accession
0001437749-20-002042
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Stock Option
2020-02-06$0.00/sh+25,000$25→ 31,250 totalExercise: $1.06Exp: 2030-02-06→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]Stock options will vest one-third on each of the first three anniversaries of the date of grant.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeother
Related Parties
1- filerCIK 0001762349
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:17 PM ET
- Size
- 5.0 KB